Page last updated: 2024-11-08

alanine and Dyspnea

alanine has been researched along with Dyspnea in 5 studies

Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"Severe sepsis and septic shock syndromes were observed in 7 (53."1.56Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. ( Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Choi, YJ1
Song, JY1
Hyun, H1
Nham, E1
Yoon, JG1
Seong, H1
Noh, JY1
Cheong, HJ1
Kim, WJ1
Chao, JY1
Derespina, KR1
Herold, BC1
Goldman, DL1
Aldrich, M1
Weingarten, J1
Ushay, HM1
Cabana, MD1
Medar, SS1
Berlin, DA1
Gulick, RM1
Martinez, FJ1
Myers, CN1
Scott, JH1
Criner, GJ1
Cordova, FC1
Mamary, AJ1
Marchetti, N1
Shenoy, KV1
Galli, JA1
Mulhall, PD1
Brown, JC1
Shigemura, N1
Sehgal, S1
Matias, WR1
Vaidya, A1
Brigl, M1
Bebell, LM1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study.[NCT04407260]136 participants (Actual)Observational2020-03-06Completed
Nation-wide Cross-sectional Survey on Current Pharmacological Practices in Severe COVID-19[NCT04691921]1,055 participants (Actual)Observational2021-01-04Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for alanine and Dyspnea

ArticleYear
Severe Covid-19.
    The New England journal of medicine, 2020, Dec-17, Volume: 383, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID

2020
Severe Covid-19.
    The New England journal of medicine, 2020, Dec-17, Volume: 383, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID

2020
Severe Covid-19.
    The New England journal of medicine, 2020, Dec-17, Volume: 383, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID

2020
Severe Covid-19.
    The New England journal of medicine, 2020, Dec-17, Volume: 383, Issue:25

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID

2020

Other Studies

4 other studies available for alanine and Dyspnea

ArticleYear
Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment.
    Medicine, 2022, Sep-23, Volume: 101, Issue:38

    Topics: Adenosine Monophosphate; Aged; Alanine; Anti-Bacterial Agents; C-Reactive Protein; COVID-19 Drug Tre

2022
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
    The Journal of pediatrics, 2020, Volume: 223

    Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea

2020
COVID-19 in lung transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents;

2020
A Patient with Fever and Dyspnea.
    The New England journal of medicine, 2020, Nov-05, Volume: 383, Issue:19

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Combined Modality Ther

2020